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Abstract
A role for EF-hand calcium-binding protein Mts1 (S100A4) in the phosphorylation and the assembly of myosin filaments
was studied. The nonmuscle myosin molecules form bipolar filaments, which interact with actin filaments to produce a
contractile force. Phosphorylation of the myosin plays a regulatory role in the myosin assembly. In the presence of calcium,
Mts1 binds at the C-terminal end of the myosin heavy chain close to the site of phosphorylation by protein kinase CK2
(Ser1944). In the present study, we have shown that interaction of Mts1 with the human platelet myosin or C-terminal
fragment of the myosin heavy chain inhibits phosphorylation of the myosin heavy chain by protein kinase CK2 in vitro. Mts1
might also bind directly the L subunit of protein kinase CK2, thereby modifying the enzyme activity. Our results indicate that
myosin oligomers were disassembled in the presence of Mts1. The short C-terminal fragment of the myosin heavy chain was
totally soluble in the presence of an equimolar amount of Mts1 at low ionic conditions (50 mM NaCl). Depolymerization was
found to be calcium-dependent and could be blocked by EGTA. Our data suggest that Mts1 can increase myosin solubility
and therefore suppress its assembly. ß 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
Nonmuscle myosin II is a hexameric protein com-
posed of one pair of heavy chains along with two
pairs of light chains. Each heavy chain consists of
three domains: a globular head domain containing
ATP- and actin-binding sites, an K-helical coiled-coil
rod domain, and a C-terminal nonhelical tail do-
main. There are at least two nonmuscle myosin
heavy chain (MHC) isoforms named MHCIIA and
MHCIIB; the amino acid sequences of heavy chains
of di¡erent isoforms are highly homologous in the
head and rod domains but exhibit the most di¡er-
ences in the nonhelical tail domains [1].
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The functional role of myosin II in nonmuscle cells
in cell migration, cytokinesis and morphogenesis dur-
ing development has been well established [2^4]. The
myosin molecules form bipolar ¢laments, which in-
teract with actin ¢laments to produce a contractile
force. In vivo, ¢laments are dynamic structures,
which undergo assembly, disassembly and distribu-
tion to particular cellular location [5]. In fact, the
assembly of myosin II is essential for each of its
cellular functions. It is not known, however, what
is the speci¢c mechanism that regulates formation
of bipolar ¢laments.
It is known that phosphorylation of the heavy
chains plays a regulatory role in myosin assembly
[1]. Two kinases, protein kinase C (PKC) and protein
kinase CK2 (CK2), have been shown to catalyze the
phosphorylation of heavy chains. PKC phosphory-
lates the single Ser1917 in MHCIIA [6] and multiple
serines near the C-terminal end in the MHCIIB iso-
form [1]. CK2 phosphorylates a single Ser1944 in the
non-helical tail domain of the heavy chain of both
isoforms [7,8]. The e¡ects of the phosphorylation on
assembly are isoform-speci¢c: phosphorylation of
heavy chain inhibits the assembly of MHCIIB,
whereas the assembly of MHCIIA is una¡ected [1].
Myosin isolated at low ionic strength in vitro
forms insoluble bipolar ¢laments, but within the cells
at the same ionic strength it remains soluble [9].
These facts suggest that interaction with other pro-
teins could be an alternative mechanism for the reg-
ulation of myosin assembly/disassembly. It has been
shown that interaction of myosin with di¡erent iso-
forms of cytoplasmic actin speci¢cally regulates lo-
calization and activity of myosin II [10].
The mts1 (S100A4) gene, named also as p9Ka,
pEL98, calvasculin and CAPL, encodes an 11.7
kDa polypeptide that belongs to the S100 family
proteins. S100 proteins are members of a large family
of ‘EF-hand’ calcium-binding proteins which have a
common mechanism of action [11]. Almost all S100
proteins are dimeric in the solution. These proteins
bind calcium, causing conformational changes which
allow them to interact with target proteins, regulat-
ing their activity [12].
High level of mts1 expression correlates with the
metastatic potential of tumor cells [13,14] and the
induction of mts1 expression in some cell system con-
verts the nonmetastatic phenotype into a metastatic
one [15,16]. Studies performed in mts1 transgenic
animals demonstrate clearly that the mts1 gene is
involved in tumor progression and metastasis
[17,18]. However, there is no mechanistic explanation
of this phenomenon to date.
In the presence of calcium, Mts1 binds actin [19],
tropomyosin [20], and the heavy chain of nonmuscle
myosin IIA [21]. The Mts1-binding site is located at
the C-terminal end of the MHC. Binding of Mts1 to
myosin inhibits PKC phosphorylation of MHC in
vitro [22], as well as promotes destabilization of my-
osin ¢laments [23]. It was therefore proposed that
Mts1 modulates cell motility by regulating the phos-
phorylation of the myosin heavy chain [22].
In our previous work we mapped the region of
MHCIIA that interacts with the Mts1 protein [22].
This region is located between amino acids 1909 and
1937 close to the site of phosphorylation by CK2
(Ser1944). In the present study, we have shown
that interaction of Mts1 with human platelet myosin
inhibits phosphorylation of MHC by CK2 in vitro.
Myosin in vitro exists in either the polymerized or
the monomeric form depending on ionic strength
[24]. We describe the e¡ects of Mts1 on solubilization
of recombinant myosin tail fragment at low ionic
conditions. The results presented suggest that the
binding of Mts1 to the heavy chain of myosin may
control assembly of nonmuscle myosin ¢laments.
2. Materials and methods
2.1. Preparation of the proteins
Myosin was isolated from outdated platelet con-
centrates as described [22]. Recombinant fragments
of the MHC, Hmyo4, Myodel 3, Myodel 4 and
Hmyo4-3B [22] and recombinant Mts1 were puri¢ed
on Ni-NTA resin as His6-tagged proteins according
to the recommendations of the manufacturer (Qia-
gen) in denatured or native (Mts1) conditions. De-
phosphorylated casein was purchased from Sigma.
2.2. CK2 phosphorylation assay
Reactions were performed in a mixture (25 Wl)
containing 50 mM Tris-HCl pH 7.6, 0.1 M NaCl,
10 mM MgCl2, 4 mM CaCl2, 2 mM dithiothreitol,
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50 WM ATP (Amersham Pharmacia Biotech), 2 WCi
[Q-32P]ATP (5000 Ci/mmol, Amersham Pharmacia
Biotech) for 15 min at 30‡C. CK2 was purchased
from New England BioLabs, and 50 units were ap-
plied per reaction. Reactions were terminated by
adding an equal volume of 2USDS-loading bu¡er
and proteins were separated on 15% SDS-PAGE.
Gels were ¢xed in 5% trichloroacetic acid, dried
and exposed to Kodak X-ray ¢lm.
2.3. Tryptic phosphopeptide mapping
Platelet myosin (1 WM) or recombinant Hmyo4-3B
(1 WM) were phosphorylated by CK2 in the absence
or presence of the Mts1 (27 WM). Reaction was per-
formed in the presence of the 15 WM ATP (Amer-
sham Pharmacia Biotech), 25 WCi [Q-32P]ATP (5000
Ci/mmol, Amersham Pharmacia Biotech). Labeled
proteins were resolved on 4^20% SDS-PAGE fol-
lowed by electroblotting to a nitrocellulose mem-
brane (Hybond-C Extra, Amersham Pharmacia Bio-
tech). Bands corresponding to the positions of the
MHC or Hmyo4-3B were excised. Tryptic digestion
and two-dimensional phosphopeptide analysis of the
samples were performed as described by [25].
2.4. Blot overlay analysis
Blot overlay was carried out as described [21] in
the presence of 1 mM CaCl2 or 1 mM EGTA.
2.5. Sedimentation analysis
Assay was performed as described [26] with mod-
i¢cations. Brie£y, Hmyo4 and Hmyo4-3B (100 Wl, 0.1
mg/ml) were dialyzed against a range of salt concen-
trations (50^400 mM NaCl) in the sedimentation
bu¡er (25 mM MES pH 6.0, 2 mM MgCl2, 1 mM
CaCl2) in the absence or presence of the Mts1 (0.1
mg/ml) during 5 h at RT. After dialysis, proteins
were centrifugated at 20 000Ug for 10 min. Super-
natants were analyzed in 15% SDS-PAGE and the
amounts of proteins determined by densitometer
(LKB). The solubility of the MHC peptides was esti-
mated as a percentage of the total solubilized pro-
tein.
Prior the sedimentation assay with the phosphor-
ylated form of the Hmyo4-3B, it was dialyzed against
0.6 M NaCl, 10 mM MES pH 6.0 and divided in
four equal parts for the assay. Sedimentation analy-
sis was performed in the presence of an excess
amount of BSA (bu¡er with 1 mM CaCl2) and in
the presence of an excess amount of Mts1 (bu¡er
with 1 mM CaCl2 or 5 mM EGTA).
2.6. Disassembling assay
Hmyo4-3B (100 Wl, 0.1 mg/ml) was dialyzed
against sedimentation bu¡er (50 mM NaCl) during
5 h at RT in two parallel bags. Hmyo4-3B suspen-
sion was centrifugated at 20 000Ug for 10 min. The
supernatant was removed and the pellet washed in
the same sedimentation bu¡er. The Hmyo4-3B pellet
was resuspended in 100 Wl of the sedimentation bu¡-
er containing either Mts1 (0.3 mg/ml) or 600 mM
NaCl. Centrifugation (20 000Ug, 10 min) was per-
formed after 1 h incubation at room temperature.
Equal volumes of aliquots were loaded on the 15%
SDS-PAGE. The gel was stained by Coomassie blue.
2.7. Analytical ultracentrifugation
Sedimentation velocity experiments were carried
out using a Beckman XL-A analytical ultracentrifuge
(Beckman-Coulter, Palo Alto, CA, USA) with an
AN60 Ti 4-hole rotor. Protein solutions were loaded
into ultracentrifuge cells containing Epon two-chan-
nel centerpieces with 12 mm pathlengths and quartz
windows. The loading concentrations of Mts1/myo-
sin proteins were 1.5, 0.75 and 0.3 mg/ml. Samples
were centrifuged at 40 000 rpm at 20‡C. Absorbance
traces at 280 nm were taken every 5 min.
The solvent density and partial speci¢c volume of
Mts1 were determined by the method described in
[27] using the program SEDNTERP, and were found
to be 1.00256 and 0.7248 g/ml respectively.
2.8. Analysis of centrifugation data
The data were analyzed using the program SedFit
[28]. This produces a molecular weight distribution
for the velocity data by modeling solutions of the
Lamm equation using maximum entropy regulariza-
tion.
This method requires a prior estimate of the fric-
tional coe⁄cient of the distribution. As this was not
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available, solutions were initially generated using a
frictional coe⁄cient of 1.0. This value was then
£oated in a subsequent ¢tting routine and was found
to have a value of 1.299. After a ¢t had been
achieved, the robustness of the distributions was as-
certained by 1000 runs of a Monte Carlo simulation.
From these data the 68% and 95% con¢dence inter-
vals were generated.
2.9. Dynamic light scattering (DLS)
The di¡usion coe⁄cient (Dt) and the calculated
molecular mass (MW) were determined by means
of DLS using a Dyna Pro 801 Molecular Sizing In-
strument (Protein Solutions, Charlottesville, VA,
USA). All readings were recorded at 18‡C. Protein
solutions in 20 mM HEPES pH 7.5, 400 mM NaCl,
5 mM CaCl2 were ¢ltered through 0.1 and 0.02 WM
Whatman membranes to remove dust and other par-
ticulates and injected into a 25 Wl cell (cuvette) and
illuminated by a 25 W 750 nm wavelength laser.
Data were collected by 250 000 counts/s with the
maximum acquisition time 20 s. In order to calculate
MW, data were ¢tted using the Dynamics Version
4.0 software package (Protein Solutions) [29].
3. Results
3.1. Mts1 inhibits CK2 phosphorylation of MHC
in vitro
In our previous study we provided direct evidence
that Mts1 interacts with the C-terminus of non-
Fig. 1. E¡ect of Mts1 on the phosphorylation of the platelet myosin or MHC fragment, Hmyo4-3B, by CK2 in vitro. 1 WM of plate-
let myosin (A or B, lanes 1^4) or 1 WM of Hmyo4-3B (A or B, lanes 5^8; C or D, lanes 1^4) were phosphorylated by CK2 as de-
scribed in Section 2. Lanes: 1 (A^D), phosphorylation in the absence of Mts1; 2^4 and 6^8 (A,B), phosphorylation in the presence of
3, 9, 27 WM of Mts1; 2^4 (C,D), phosphorylation in the presence of 0.3, 1, 3 WM of Mts1. (A,C) Autoradiogram of phosphorylation
by CK2. (B,D) Coomassie blue stained gels.
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muscle MHCIIA [22]. The region of interaction on
MHC is located within the area between Asp1909
and Arg1937, nearby Ser1944 which is known to be
a unique CK2 phosphorylation site both in vitro and
in vivo [7,8]. We therefore tested whether Mts1 af-
fects the phosphorylation of MHC by CK2 in vitro.
Human platelet myosin and 199 amino acid recombi-
nant fragment Hmyo4-3B that corresponded to the
C-terminal part of the MHC, were phosphorylated
by CK2 both in the presence and absence of Mts1.
Labeled phosphorylated proteins were resolved on
SDS-PAGE, stained by Coomassie blue and exposed
to X-ray ¢lm. As shown in Fig. 1, Mts1 inhibited
phosphorylation of native (Fig. 1A, lanes 1^4) or
recombinant MHC (Fig. 1A, lanes 5^8; Fig. 1C)
by CK2 in a dose-dependent manner. The maximal
inhibition of the CK2 phosphorylation of Hmyo4-3B
was observed when both components were present at
equimolar ratios (Fig. 1C).
The excess amount of the Mts1 did not block
phosphorylation of the native MHC or recombinant
Hmyo4-3B completely (Fig. 1A, lanes 3 and 4, 7 and
8), which may be due to the appearance of novel
phosphorylation sites on the myosin molecule in
the presence of Mts1. In order to check the possible
alterations in the pattern of the CK2-mediated phos-
phorylation of the native or recombinant MHC in
the presence of the Mts1, tryptic phosphopeptide
analysis was performed. Two myosin substrates
were phosphorylated by CK2 in the absence or pres-
ence of an excess of Mts1, then subjected to SDS-
PAGE followed by transfer to the nitrocellulose
membrane by electroblotting. Bands corresponding
to the MHC or Hmyo4-3B were excised and treated
by trypsin, and equal amounts of radioactive materi-
als from all samples were loaded on cellulose thin-
layer plates. Tryptic phosphopeptide analysis re-
vealed similar phosphopeptide maps of the native
MHC and recombinant Hmyo4-3B (Fig. 2A,C).
There are no additional sites of the phosphorylation
of MHC or Hmyo4-3B in the presence of excess of
Mts1 (Fig. 2B,D). The presence of two spots on the
phosphopeptide maps resulted from incomplete tryp-
sin digestion of the phosphopeptide containing
Ser1944. CK2 phosphorylation of the mutated
Hmyo4-3B (where Ser1944 was substituted by ala-
nine) was abolished (data not shown).
In order to study the mechanism of the Mts1-
mediated inhibition of the MHC phosphorylation
by CK2, we tested whether Mts1 a¡ects the CK2
Fig. 2. Tryptic phosphopeptide maps of the CK2 phosphorylated platelet MHC or Hmyo4-3B. Tryptic phosphopeptides of the platelet
MHC (A,B) or Hmyo4-3B (C,D) phosphorylated by CK2 in the absence (A,C) or presence of Mts1 (B,D) were separated in two di-
mensions as described in Section 2. The plates were exposed to X-ray ¢lm (exposure time 24 h) at 370‡C. Origins are marked by the
arrows.
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phosphorylation of other substrates. As CK2 sub-
strates, we have chosen two di¡erent synthetic pep-
tides, dephosphorylated casein and deletion mutants
of MHC, Myodel3 and Myodel4. We have shown
before that partial deletion of the Mts1 binding site
within the recombinant C-terminal fragment of
MHC prevented its interaction with Mts1 in blot-
overlay assay [22]. Surprisingly, Mts1 a¡ected di¡er-
ently the phosphorylation of those CK2 substrates
which did not bind this protein in vitro. Mts1 had
a mild stimulatory e¡ect on the CK2 phosphoryla-
tion of the synthetic peptides (data not shown). By
contrast, CK2 phosphorylation of casein was stimu-
lated in the presence of Mts1 (Fig. 3A, lanes 1 and
2). When the phosphorylation of di¡erent deletion
mutants of Hmyo4 was analyzed, we observed a
mild inhibition (Fig. 3C, lanes 3 and 4) or mild stim-
ulation (Fig. 3C, lanes 5 and 6) of the CK2-mediated
phosphorylation in the presence of Mts1.
To explain how Mts1 might a¡ect the phosphory-
lation of the CK2 substrates, which do not physically
interact with this protein, we suggested that Mts1
might bind directly to the enzyme thereby modifying
its activity.
To test this hypothesis, we performed blot-overlay
assay. Hmyo4-3B, casein and CK2 were resolved in
SDS-PAGE, transferred to the nitrocellulose mem-
brane and incubated with Mts1 followed by staining
with the anti-Mts1 antibody. Mts1 strongly inter-
acted with Hmyo4-3B and to a lesser extent with
the L subunit of CK2 (Fig. 4, lanes 1 and 3). The
observed interaction was Ca-dependent, since it was
abolished in the presence of EGTA (data not
shown). Mts1 did not bind to the K subunit of
CK2 or casein (Fig. 4, lanes 2 and 3).
3.2. Mts1 induces disassembly of the C-terminal
fragments of the MHC in vitro
Nonmuscle myosin IIA is known to form ¢lament
structures under physiological conditions in vitro.
Previously, it was shown that Mts1 can destabilize
myosin ¢lament formation in a Ca2-dependent
manner [23]. However, the mechanism of the desta-
bilization remained unclear.
In order to investigate the role of the Mts1 in the
disassembling of the myosin ¢laments, we used two
recombinant fragments of MHC that contained the
Mts1-binding site and fragments of the MHC rod
domain of di¡erent sizes, Hmyo4 (577 amino acids)
Fig. 3. In£uence of Mts1 on the phosphorylation of casein, Hmyo4 and its deleted variants (Myodel3 and Myodel4) by CK2. (A) De-
phosphorylated casein (1 WM) was phosphorylated by CK2 in the absence (lanes 1, 3) or presence of an excess amount (27 WM) of
Mts1 (lanes 2, 4). (B,C) 1 WM of Hmyo4 or 1 WM of its deleted variants, Myodel3 (deletion of amino acids 1909^1926) and Myodel4
(deletion of amino acids 1926^1939), was phosphorylated in the absence (lanes 1, 3, 5) or presence of an excess amount (27 WM) of
Mts1 (lanes 2, 4, 6). (A, lanes 1, 2, and C) Autoradiogram of phosphorylation by CK2. (A, lanes 3, 4, and B) Coomassie blue stained
gels.
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and Hmyo4-3B (199 amino acids) [22]. Sedimenta-
tion assays were performed both in the absence and
presence of Mts1. The NaCl concentration was var-
ied in the range of 50^400 mM NaCl for each assay
condition.
Proteins were mixed in 600 mM NaCl and dialyzed
to low salt concentrations over a period of 5 h. In-
soluble aggregates were removed by centrifugation
and supernatants were analyzed by SDS-PAGE. As
shown in Fig. 5A, both fragments had similar salt-
dependent assembly characteristics in the absence of
the Mts1 protein. Surprisingly, the short C-terminal
fragment of the MHC, Hmyo4-3B, was totally solu-
ble in the presence of an excess amount of Mts1 at
low salt concentrations (50 mM NaCl). By contrast,
the e¡ect of Mts1 on the assembly-disassembly of
Hmyo4 was not detected at di¡erent salt concentra-
tions by this method.
We studied the concentration dependence on the
oligomeric state of Hmyo4-3B in 50 mM NaCl by
incubating it with increasing concentrations of Mts1
(Fig. 5B). It was found that the assembly of the
Hmyo4-3B was proportional to the amount of
Mts1 added (Fig. 5B, lanes 1^5). At an equimolar
ratio the Hmyo4-3B was found to be entirely depoly-
merized and recovered in supernatant fraction (Fig.
Fig. 4. Blot overlay analysis of the interaction of Mts1 with
CK2 substrates and CK2 subunits. Equimolar amounts of
Hmyo4-3B (lane 1), dephosphorylated casein (lane 2) and CK2
holoenzyme (lane 3) were separated in 15% SDS-PAGE, trans-
ferred to the membrane and incubated with Mts1 (3 Wg/ml) in
the presence of 1 mM CaCl2. Anti-mts1 antibody detected pro-
tein targets of the Mts1 (Hmyo4-3B, L subunit of CK2).
Fig. 5. Assembly/disassembly of the recombinant C-terminal
MHC fragments in the presence of Mts1. (A) Self-assembly of
Hmyo4 or Hmyo4-3B in the absence or presence of Mts1 at
di¡erent salt concentrations. (B) 15% SDS-PAGE shows sedi-
mentation analysis of Hmyo4-3B in the presence of Mts1. The
blocks labeled 5 mM CaCl2 and 5 mM EGTA represent the
protein composition of the supernatants of the Mts1 and
Hmyo4-3B mixture following 10 min incubation at 15‡C and
centrifugation at 14 000Ug for 5 min. Lanes 1^4 and 6^9 repre-
sent samples with 16 Wg of Hmyo4-3B and di¡erent amounts of
Mts1: 0, 2, 4, 8 Wg in 10 mM MES, pH 6.0, 5 mM CaCl2 or
5 mM EGTA and 50 mM NaCl. Lanes 5 and 10 represent
samples containing 16 Wg of Hmyo4-3B at 400 mM NaCl and
in the absence of Mts1. (C) Disassembly of Hmyo4-3B in the
presence of Mts1 (lane 1) or bu¡er containing 600 mM NaCl
(lane 2).
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5B, lane 4 and 5 as control). Depolymerization was
found to be calcium-dependent and could be blocked
by EGTA (Fig. 5B, lanes 6^10).
When Mts1 was added to the pellet of Hmyo4-3B,
formed at low salt conditions, the solubilization was
even more e⁄cient than that in the presence of 600
mM NaCl (Fig. 5C).
To try and ascertain the precise nature of these
low ionic strength soluble aggregates we conducted
DLS experiments along with sedimentation velocity
experiments in the analytical ultracentrifuge. The
DLS technique demonstrated that all Hmyo4-3B
samples tested are interpreted as polydisperse and
therefore dynamic regularization analysis was em-
ployed to resolve the distribution. The regularization
analysis presents an optimal size resolution based on
its own computations of the residual errors. Table 1
shows that under conditions when Hmyo4-3B is
‘soluble’ (0.4 M NaCl) it represents a mixture of
oligomers with a calculated MW from 154 to 1036
kDa. The analysis of low molecular weight species
was di⁄cult since they were masked by large myosin
aggregates. However, they were revealed by analyti-
cal ultracentrifugation under the conditions when
large aggregates were sedimented to the bottom of
the cell at the beginning of the centrifugation run. In
the presence of an equimolar amount of S100A4
protein we observed redistribution of myosin aggre-
gates. High molecular weight species (about 1000
kDa) disappeared whereas the most abundant species
were 154 kDa. We did not detect any evidence of
complex formation using DLS, since the complex
would lead only to very small changes in the di¡u-
sion coe⁄cient. In the DLS experiments we only be-
lieved that myosin ¢laments are disassembled in the
presence of S100A4. The analytical ultracentrifuga-
tion experiments in contrast show that the mass dis-
tribution is centered around 30^40 kDa, with evi-
dence of higher order species right up to 250 kDa
(Fig. 6). As dependence of scatter is proportional to
the square of the molecular weight, these heavier
species would only need to be in a small proportion
to generate a molecular weight of 154 kDa seen in
the dynamic light scattering. However, sedimentation
techniques depend only on the weight average, which
is proportional to molecular weight, therefore the
results show a smaller proportion of the heavier spe-
cies with this technique.
The data therefore show that in the presence of
Table 1
Results of dynamic light scattering studies on the Hmyo4-3B myosin fragment and its complex with Mts1
Di¡. coe¡. (cm/s2) Radius (nm) % scatter % mass MW (kDa)
Myo4-3B
4.4e-007 4.5 3.9 11.9 154
3.1e-007 6.37 71.6 78.1 408
2.2e-007 8.85 24.6 10.0 1036
Myo4-3B/Mts1
4.4e-007 4.51 31.8 56.9 154
3.1e-007 6.37 68.2 43.1 408
2.2e-007 8.85 0.0 0.0 ^
All values represent the average of 40 measurements. Measurements were made at 17.9‡C. Mean hydrodynamic radius derived from
the measured translational di¡usion coe⁄cient using the Stokes-Einstein equation.
Fig. 6. Size distribution of soluble myosin species in the pres-
ence of S100A4. Size distribution of soluble species generated
using maximum entropy regularization as described in [28].
Mass distributions were generated using an empirically deter-
mined frictional coe⁄cient of 1.299. The non-zero values at
higher molecular weight values indicate the presence of a range
of higher order aggregates. The lines in the plot are con¢dence
limits generated from 1000 runs of a Monte-Carlo simulation:
they represent the mean (the middle line in the plot), then the
68% con¢dence limit, then the 95% con¢dence limit.
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S100A4 there appears to be a ‘solubilization e¡ect’
on the myosin fragment. This is probably due to the
disaggregation of high molecular weight species in
the presence of S100A4. We suggest that Mts1 may
participate in the disorganization of myosin ¢laments
by sequestering myosin monomers, leading to a total
inhibition of myosin assembly.
We next tested whether the CK2 phosphorylation
a¡ects the ability of Mts1 to solubilize the recombi-
nant MHC. Hmyo4-3B was phosphorylated by CK2
and subsequently used in sedimentation assay with
or without Mts1. At low salt concentration (50
mM NaCl), Hmyo4-3B formed polymers and pre-
cipitated independently of whether it was CK2-phos-
phorylated or not (Fig. 7, lanes 1 and 2, and 5 and
6). In the presence of Mts1, the solubilization of
Hmyo4-3B was also phosphorylation-independent
(Fig. 7, lanes 3 and 7), but occurred only in the
presence of calcium (Fig. 7, lanes 4 and 8).
4. Discussion
4.1. Mts1-MHCIIA interaction
The present report provides new data consistent
with the ¢nding that the destabilization of the ¢la-
ments of nonmuscle myosin IIA is mediated by the
binding of Mts1 [23]. Mts1 interacts with a speci¢c
region (amino acids 1909^1937) of MHC localized in
the junction between the K-helical coiled-coil domain
and the C-terminal nonhelical domain. The binding
is calcium-dependent and EGTA blocks this interac-
tion [22].
It has been shown that the regions at or close to
the C-terminus of the myosin rod are critical for
myosin assembly. Deletion of the C-terminal nonhel-
ical domain or site-directed mutagenesis completely
prevented myosin self-assembly [30,31]. Moreover,
the binding of monoclonal antibodies raised against
the C-terminus blocks ¢lament assembly [32]. There-
fore, proteins binding at the tail of myosin are likely
to have an in£uence on its function.
Our data show that interaction of the Mts1 with
the C-terminal fragment of the MHC prevents self-
assembly of the myosin ¢laments. This is a highly
e⁄cient process as when the Mts1 protein is added
to the precipitate of the tail fragment of MHC at low
ionic strength it completely solubilizes the pellet.
The e¡ect of the Mts1 on the assembly/disassem-
bly of the MHC at low ionic conditions is not phos-
phorylation-dependent. Mts1 can bind to CK2 or
PKC phosphorylated MHCIIA regulating its assem-
bly/disassembly in calcium-dependent way.
In vivo, nonmuscle myosin IIA can be phosphor-
ylated by CK2 or PKC [6^8]. However, the physio-
Fig. 7. Assembly of the CK2 phosphorylated Hmyo4-3B in the presence of Mts1. Equal amounts of Hmyo4-3B, nonphosphorylated
or phosphorylated by CK2, were dialyzed against bu¡er (600 mM NaCl, 10 mM MES pH 6.0) and divided into four parts. Sedimen-
tation assay was performed in the presence of BSA and 1 mM CaCl2 (lanes 2 and 6), in the presence of Mts1 and 1 mM CaCl2 (lanes
3 and 7) or in the presence of Mts1 and 5 mM EGTA (lanes 4 and 8). Lanes 1 and 5, nonphosphorylated or phosphorylated Hmyo4-
3B used for sedimentation assay. (A) Coomassie blue staining of the gel. (B) Autoradiogram of the gel.
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logical function of the PKC or CK2 phosphorylation
of the MHCIIA is not known. The interaction of the
Mts1 with MHCIIA inhibits its phosphorylation by
PKC or CK2.
The fact that myosin assembly into polymer struc-
tures in nonmuscle cells is a very dynamic process
raises the question of how this process is regulated.
It is possible that, in vivo, unassembled myosin
might be stabilized as soluble complexes by Mts1.
Binding of Mts1 to myosin might physically prevent
the myosin tail from assembling, and stabilize a
monomeric structure.
It has been shown that another myosin-binding
protein isolated from the sea urchin egg binds to
the head-rod junction of myosin II [33]. Such binding
stabilizes a myosin conformation, which maintains
myosin solubility under low ionic conditions [34].
Electron microscopy studies of the backbone struc-
ture of self-assembled smooth muscle myosin ¢la-
ments have shown that the backbone is built up of
interacting C-terminal parts of myosin tails [35].
Moreover, it has been shown that hydrophobic inter-
actions play a role in myosin II ¢lament assembly.
Two regions that were required for MHCIIA ¢la-
ment assembly showed a high hydrophobicity of sur-
face residues. It was suggested that hydrophobic in-
teractions mediate the antiparallel packing in the
¢lament core [36]. Thus it is likely that interaction
of Mts1, which is an acidic protein, with the hydro-
phobic surface of assembled ¢laments may disrupt
hydrophobic interactions and lead to disassembly
of myosin ¢laments.
The fact that Mts1 can disaggregate the MHC
oligomers at physiological conditions in vitro sug-
gests an important role, which Mts1 might play in
modulating the myosin functions in vivo.
4.2. The regulation of CK2 by Mts1
CK2 consists of two K and two L subunits [37].
The regulatory L subunit is responsible for activity,
speci¢city and stability of the K subunit [38] and the
substrate speci¢city of the holoenzyme [39]. Here, we
have demonstrated that Mts1 interacts with the L
subunit of CK2 in vitro, a¡ecting the holoenzyme
activity. Our results show that the interaction of
Mts1 with the L subunit of CK2 can stimulate (ca-
sein, Myodel4) or inhibit (Myodel 3) the activity of
CK2. It was shown before that some proteins change
the activity of CK2 by interacting with the L subunit.
For example, the binding of p21/WAF to the L sub-
unit inhibits phosphorylation of p53 by CK2 [40].
Our results therefore show that Mts1 belongs to
this group of the regulatory proteins.
The mechanism by which Mts1 inhibits MHC
phosphorylation by CK2 is presently not clear. The
inhibition might result from down-regulation of the
enzymatic activity. Alternatively, Mts1, when bound
to MHC, might induce conformational alterations in
the MHC molecule a¡ecting the accessibility of the
phosphorylation site.
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